EUVIMEDEUVIMED entdecken
Crossref

Hepatic complications of peptide receptor radionuclide therapy with Lutetium-177 and Yttrium-90 in patients with neuroendocrine neoplasm

Barbara Bober, Marek Saracyn, Arkadiusz Lubas, Maciej Kolodziej, Dorota Brodowska-Kania, Waldemar Kapusta, Grzegorz Kaminski

Nuclear Medicine Review · 31.01.2022 · 25 (1) · 54-61

DOI: 10.5603/nmr.a2022.0016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuclear Medicine Review, online erschienen am 31.01.2022. Verfasst von Barbara Bober und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Isotope Therapy, Military Institute of Medicine, Warsaw, Poland. barbara.bober@tlen.pl. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Organometallic Compounds. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsOrganometallic CompoundsHumansLutetiumOctreotidePositron-Emission TomographyRadioisotopesRadionuclide ImagingReceptors, PeptideYttrium Radioisotopes

Stichwörter der Autor:innen

PRRTcomplications of radioisotope treatmentneuroendocrine neoplasmsradioisotope treatmenttreatment of neuroendocrine neoplasms

Substanzen

Organometallic CompoundsRadioisotopesReceptors, PeptideYttrium Radioisotopescopper dotatate CU-64Yttrium-90LutetiumLutetium-177Octreotide

Autor:innen und Institutionen

  • Department of Endocrinology and Isotope Therapy, Military Institute of Medicine, Warsaw, Poland. barbara.bober@tlen.pl.
  • Department of Endocrinology and Isotope Therapy, Military Institute of Medicine, Warsaw, Poland.
  • Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.

Zitieren

APA

Bober, B., Saracyn, M., Lubas, A., Kolodziej, M., Brodowska-Kania, D., Kapusta, W., & Kaminski, G. (2022). Hepatic complications of peptide receptor radionuclide therapy with Lutetium-177 and Yttrium-90 in patients with neuroendocrine neoplasm. Nuclear Medicine Review, 25(1), 54-61. https://doi.org/10.5603/nmr.a2022.0016

Vancouver

Bober B, Saracyn M, Lubas A, Kolodziej M, Brodowska-Kania D, Kapusta W, et al. Hepatic complications of peptide receptor radionuclide therapy with Lutetium-177 and Yttrium-90 in patients with neuroendocrine neoplasm. Nuclear Medicine Review. 2022;25(1):54-61. doi:10.5603/nmr.a2022.0016

BibTeX
@article{Bober2022,
  author = {Bober, Barbara and Saracyn, Marek and Lubas, Arkadiusz and Kolodziej, Maciej and Brodowska-Kania, Dorota and Kapusta, Waldemar and Kaminski, Grzegorz},
  title = {Hepatic complications of peptide receptor radionuclide therapy with Lutetium-177 and Yttrium-90 in patients with neuroendocrine neoplasm},
  journal = {Nuclear Medicine Review},
  year = {2022},
  volume = {25},
  number = {1},
  pages = {54--61},
  doi = {10.5603/nmr.a2022.0016}
}
Kostenlos starten →